ipilimumab,nivolumab
bms
[]
sustained survival with chemo immunotherapy among patients with metastatic gej cancer is great to see! 3 year follow up of checkmate 649 by more benefit with higher pdl-1 score #gi23
Medical Director, GI Oncology Program - AdventHealth Cancer Institute. Passionate about clinical research, education and pt-prov communication. #gicancer #meded